-
公开(公告)号：JP2007176958A
公开(公告)日：2007-07-12
申请号：JP2007092969
申请日：2007-03-30
Applicant: Ucb Farchim Sa , ユセベ ファルシム ソシエテ アノニム
Inventor： FANARA DOMENICO , GUICHAUX ANTHONY , BERWAER MONIQUE , DELEERS MICHEL
IPC: A61J1/03 , A61K31/475 , A61K20060101 , A61K9/20 , A61K9/24 , A61K9/26 , A61K31/137 , A61K31/495 , A61K47/36 , A61K47/38 , A61P11/00 , A61P11/02 , A61P27/02 , A61P27/14 , A61P37/08 , A61P43/00 , C07D295/08
CPC classification number: A61K31/137 , A61K9/209 , A61K31/495 , A61K2300/00
Abstract: PROBLEM TO BE SOLVED: To provide a medicine having the practically same pharmacodynamic profiles of cetirizine and pseudoephedrine as those in a medicine administration type containing the same amount of cetirizine and pseudoephedrine discretely as the discrete active ingredients. SOLUTION: The tablet comprises at least two discrete segments, one of which mainly contains the cetirizine as the active ingredient and the other second segment mainly contains the pseudoephedrine as the active ingredient, wherein the pseudoephedrine segment and the cetirizine segment contact directly and their interfacial surface area is 2 . COPYRIGHT: (C)2007,JPO&INPIT
Abstract translation: 待解决的问题：提供具有与含有相同量的西替利嗪和伪麻黄碱作为离散活性成分的药物给药型相同的西替立嗪和伪麻黄碱具有实际相同的药效学特征的药物。 解决方案：片剂包含至少两个离散区段，其中一个主要含有西替利嗪作为活性成分，另一个第二部分主要含有伪麻黄碱作为活性成分，其中伪麻黄碱片段和西替立嗪片段直接接触， 它们的界面面积<180mm
2 。 版权所有（C）2007，JPO＆INPIT -
公开(公告)号：JP2014024866A
公开(公告)日：2014-02-06
申请号：JP2013228128
申请日：2013-11-01
Applicant: Ucb Farchim Sa , ユセベ ファルシム ソシエテ アノニム
Inventor： FANARA DOMENICO , BERWAER MONIQUE , GUICHAUX ANTHONY , DELEERS MICHEL
IPC: A61K9/10 , A61K31/495 , A61K9/00 , A61K9/08 , A61K9/14 , A61K9/16 , A61K9/20 , A61K9/24 , A61K9/28 , A61K9/68 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/16 , A61K47/22 , A61K47/26 , A61K47/36 , A61K47/38 , A61K47/40 , A61K47/42 , G01N33/53
CPC classification number: A61K9/0095 , A61K9/0056 , A61K9/0058 , A61K9/2086 , A61K9/2826 , A61K31/495
Abstract: PROBLEM TO BE SOLVED: To provide a stable pharmaceutical composition for oral administration of an active compound.SOLUTION: The pharmaceutical composition for oral administration contains at least two separate formulations. A first formulation, which contains the active compound selected from 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acids and their amides, does not contain polyols having a molecular weight of less than 950 in a molar ratio between the polyols and the active compound represented by formula I above 10. Lactose is an exception. A second formulation contains one or more solid polyols of a molecular weight of less than 3,000 and is free of any drug. The composition is a dry syrup composition.
Abstract translation: 要解决的问题：提供用于口服给予活性化合物的稳定的药物组合物。溶液：用于口服给药的药物组合物含有至少两种分开的制剂。 包含选自2- [4-（二苯基甲基）-1-哌嗪基] - 乙酸及其酰胺的活性化合物的第一制剂不含多元醇，其分子量小于950，多元醇 和上述式I表示的活性化合物。乳糖是例外。 第二种制剂含有一种或多种分子量小于3,000的固体多元醇，并且不含任何药物。 组合物是干糖浆组合物。
-
公开(公告)号：JP2012121917A
公开(公告)日：2012-06-28
申请号：JP2012051259
申请日：2012-03-08
Applicant: Ucb Farchim Sa , ユセベ ファルシム ソシエテ アノニム
Inventor： FANARA DOMENICO , BERWAER MONIQUE , GUICHAUX ANTHONY , DELEERS MICHEL
IPC: A61K9/10 , A61K31/495 , A61K9/00 , A61K9/08 , A61K9/14 , A61K9/16 , A61K9/20 , A61K9/24 , A61K9/28 , A61K9/68 , A61K47/02 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/16 , A61K47/22 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/40 , A61K47/42 , A61K47/44 , A61P11/02 , A61P29/00 , A61P37/08 , A61P43/00 , G01N33/53
CPC classification number: A61K9/0095 , A61K9/0056 , A61K9/0058 , A61K9/2086 , A61K9/2826 , A61K31/495
Abstract: PROBLEM TO BE SOLVED: To provide a stable pharmaceutical composition for oral administration of an active compound.SOLUTION: The oral drug composition includes at least two different formulations, or a first formulation including an active compound selected from 2-[4-(diphenylmethyl)-1-pyperadinyl]-acetic acid and amides thereof, the first formulation not including, except lactose, a polyol having a molecular weight of less than 950 in a mole ratio exceeding 10 of the active compound of formula I; and a second formulation including one or more solid polyols having a molecular weight of less than 3,000, the second formulation including no medicinal substances. The composition has a form of dry syrup.
Abstract translation: 待解决的问题：提供用于口服给予活性化合物的稳定的药物组合物。 口服药物组合物包含至少两种不同的制剂，或包含选自2- [4-（二苯基甲基）-1-芘二乙烯基] - 乙酸及其酰胺的活性化合物的第一制剂，第一制剂不 包括除乳糖外，分子量小于950的摩尔比超过10的式I的活性化合物的多元醇; 以及包含分子量小于3,000的一种或多种固体多元醇的第二种制剂，所述第二制剂不包括药物。 该组合物具有干糖浆的形式。 版权所有（C）2012，JPO＆INPIT
-
公开(公告)号：JP2010120963A
公开(公告)日：2010-06-03
申请号：JP2010035633
申请日：2010-02-22
Applicant: Ucb Farchim Sa , ユセベ ファルシム ソシエテ アノニム
Inventor： FANARA DOMENICO , BERWAER MONIQUE , GUICHAUX ANTHONY , DELEERS MICHEL
IPC: A61K9/10 , A61K31/495 , A61K9/00 , A61K9/14 , A61K9/16 , A61K9/20 , A61K9/28 , A61K9/68 , A61K47/02 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/16 , A61K47/22 , A61K47/36 , A61K47/38 , A61K47/40 , A61K47/42 , A61P29/00 , A61P43/00 , G01N33/53
CPC classification number: A61K9/0095 , A61K9/0056 , A61K9/0058 , A61K9/2086 , A61K9/2826 , A61K31/495
Abstract: PROBLEM TO BE SOLVED: To provide a stable pharmaceutical composition for oral administration of an active compound.
SOLUTION: The pharmaceutical composition for oral administration contains at least two separate formulations. A first formulation, which contains the active component selected from 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acids and their amides, does not contain polyols having a molecular weight of less than 950 in a molar ratio between the polyols and the active compound represented by formula I above 10. Lactose is an exception. A second formulation contains one or more solid polyols of a molecular weight of less than 3,000 and is free of any drug. The composition is a dry syrup composition.
COPYRIGHT: (C)2010,JPO&INPITAbstract translation: 待解决的问题：提供用于口服给予活性化合物的稳定的药物组合物。 解决方案：用于口服给药的药物组合物含有至少两种分开的制剂。 含有选自2- [4-（二苯基甲基）-1-哌嗪基] - 乙酸及其酰胺的活性成分的第一制剂不含多元醇，其分子量小于950，多元醇 和上述式I表示的活性化合物。乳糖是例外。 第二种制剂含有一种或多种分子量小于3,000的固体多元醇，并且不含任何药物。 组合物是干糖浆组合物。 版权所有（C）2010，JPO＆INPIT
-
公开(公告)号：NO333936B1
公开(公告)日：2013-10-28
申请号：NO20043367
申请日：2004-08-13
Applicant: UCB FARCHIM SA
Inventor： DELEERS MICHEL , FANARA DOMENICO , GUICHAUX ANTHONY , BERWAER MONIQUE
IPC: A61K9/10 , A61K9/20 , A61K9/00 , A61K9/16 , A61K9/28 , A61K9/68 , A61K31/495 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/16 , A61K47/22 , A61K47/36 , A61K47/38 , A61K47/40 , G01N33/53
Abstract: Foreliggende oppfinnelse angår farmasøytiske preparater omfattende 2-(4-(difenylmetyl)-1-piperazinyl(-eddiksyrer og polyoler for oral administrasjon .
-
Patent Agency Ranking
公开(公告)号：PL212123B1
公开(公告)日：2012-08-31
申请号：PL37029203
申请日：2003-01-14
Applicant: UCB FARCHIM SA
Inventor： FANARA DOMENICO , BERWAER MONIQUE , GUICHAUX ANTHONY , DELEERS MICHEL
-
公开(公告)号：PL206069B1
公开(公告)日：2010-06-30
申请号：PL36680002
申请日：2002-06-10
Applicant: UCB FARCHIM SA
Inventor： FANARA DOMENICO , GUICHAUX ANTHONY , BERWAER MONIQUE , DELEERS MICHEL
IPC: A61J1/03 , A61K9/20 , A61K20060101 , A61K9/24 , A61K9/26 , A61K31/137 , A61K31/495 , A61K47/36 , A61K47/38 , A61P11/00 , A61P11/02 , A61P27/02 , A61P37/08
-
公开(公告)号：AU2009203044A1
公开(公告)日：2009-08-13
申请号：AU2009203044
申请日：2009-07-27
Applicant: UCB FARCHIM SA
Inventor： GUICHAUX ANTHONY , DELEERS MICHEL , FANARA DOMENICO , BERWAER MONIQUE
IPC: A61K9/10 , A61K9/00 , A61K9/16 , A61K9/20 , A61K9/28 , A61K9/68 , A61K31/495 , A61K47/04 , A61K47/10 , A61K47/12 , A61K47/16 , A61K47/22 , A61K47/36 , A61K47/38 , A61K47/40 , G01N33/53
Abstract: The present invention relates to pharmaceutical compositions for oral administration of active compounds.
-
公开(公告)号：DK1404304T3
公开(公告)日：2009-07-13
申请号：DK02743173
申请日：2002-06-10
Applicant: UCB FARCHIM SA
Inventor： FANARA DOMENICO , GUICHAUX ANTHONY , BERWAER MONIQUE , DELEERS MICHEL
IPC: A61J1/03 , A61K9/20 , A61K20060101 , A61K9/24 , A61K9/26 , A61K31/137 , A61K31/495 , A61K47/36 , A61K47/38 , A61P11/00 , A61P11/02 , A61P27/02 , A61P37/08
Abstract: The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
-
公开(公告)号：PT1404304E
公开(公告)日：2009-06-26
申请号：PT02743173
申请日：2002-06-10
Applicant: UCB FARCHIM SA
Inventor： DELEERS MICHEL , FANARA DOMENICO , GUICHAUX ANTHONY , BERWAER MONIQUE
IPC: A61J1/03 , A61K9/20 , A61K20060101 , A61K9/24 , A61K9/26 , A61K31/137 , A61K31/495 , A61K47/36 , A61K47/38 , A61P11/00 , A61P11/02 , A61P27/02 , A61P37/08
-
-
-
-
-
-
-
-
-
Search Results
59
records
(took 0.023 seconds)
